{
  "ticker": "LLY",
  "target_date": "2025-05-01",
  "actual_date": "2025-05-01",
  "collected_at": "2025-12-08T11:42:42.933799",
  "price": {
    "open": 839.2,
    "high": 846.09,
    "low": 787.56,
    "close": 789.5792236328125,
    "volume": 12601100,
    "change_1d_pct": -11.66,
    "change_7d_pct": -4.04,
    "change_30d_pct": -5.13
  },
  "technicals": {
    "rsi_14": 59.48,
    "sma_20": 792.74,
    "sma_50": 828.49,
    "macd": 13.492,
    "macd_signal": 4.651,
    "macd_histogram": 8.841,
    "bb_upper": 916.41,
    "bb_lower": 669.06,
    "price_vs_sma20_pct": -0.4,
    "price_vs_sma50_pct": -4.7,
    "volume_ratio": 2.76
  },
  "fundamentals": {
    "market_cap": 890584956928,
    "pe_ratio": 48.67467,
    "forward_pe": 43.84157,
    "price_to_book": 37.40399,
    "price_to_sales": 14.988017,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.66,
    "pct_from_52w_low": 59.26
  },
  "macro": {
    "spy": {
      "price": 555.28,
      "change_1d_pct": 0.71,
      "change_7d_pct": 4.31
    },
    "vix": {
      "level": 24.6,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.23
    },
    "dollar_index": {
      "level": 100.25
    },
    "gold": {
      "price": 3210.0
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "The GLP-1 Saga Continues, And How",
      "source": "SeekingAlpha",
      "datetime": 1746133500,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=204931e369efb88a8dd36991182948f33ff0cf9af25198dbd417b8f9328e27c1"
    },
    {
      "headline": "S&P 500 Gains and Losses Today: Index Rises After Strong Start to Big Tech Earnings",
      "source": "Yahoo",
      "datetime": 1746131348,
      "summary": "The S&P 500 advanced 0.6% on Thursday, May 1, securing its eighth straight winning session as strong results from Microsoft and Meta helped boost tech stocks.",
      "url": "https://finnhub.io/api/news?id=527ab94a977f9ccbf53443ae576b93d08215b30404f2b26502224c0275405bad"
    },
    {
      "headline": "Eli Lilly Shares Tumble 10% After Q1 Earnings Miss Wall Street Estimates",
      "source": "Yahoo",
      "datetime": 1746128591,
      "summary": "Eli Lilly Cuts Outlook, Shares Sink on Disappointing Profit",
      "url": "https://finnhub.io/api/news?id=d828ff5e2423123ffa2acae0675093833e5518e80d55ca699c2e1a3cf07f9e5a"
    },
    {
      "headline": "Is Eli Lilly and Company (LLY) the Best Growth Stock to Buy for the Next 3 Years?",
      "source": "Yahoo",
      "datetime": 1746126869,
      "summary": "We recently published a list of the 15 Best Growth Stocks to Buy for the Next 3 Years. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other growth stocks to buy for the next 3 years. On April 29, Dan Ives of Wedbush Securities [\u2026]",
      "url": "https://finnhub.io/api/news?id=2d76d6885b11032ded2b113969ae3dfb02af1b1cd8203a182944b83f00a73705"
    },
    {
      "headline": "Why Eli Lilly (LLY) Stock Is Nosediving",
      "source": "Yahoo",
      "datetime": 1746125103,
      "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 11% in the afternoon session after the company reported weak first quarter 2025 results which included an EPS miss due to lower-than-expected profitability and full-year EPS guidance that missed significantly. On the other hand, Eli L",
      "url": "https://finnhub.io/api/news?id=3522c9043203133e08835ba29b9abeaf9c911f6819cac03bfbaf76e310378545"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-05-01",
      "description": "lly-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm"
    },
    {
      "form": "8-K",
      "date": "2025-05-01",
      "description": "lly-20250501.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/lly-20250501.htm"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353273.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353160.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/xslF345X05/wk-form4_1745353160.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}